PJ Vogt

So I try not to ask reporters about their drug use on air.

But in this case, I broke my rule, and I'm glad I did because it led to some answers that helped me settle my thinking on these drugs, at least for the moment.

I asked Jasmine Sun whether she'd tried peptides.

It's funny, it's like your view is basically like, the nice thing about a gray market is because it exists somewhere in between legal and illegal.

You don't have a massive marketing push behind it.

You have something that for the people who are willing to tolerate a little bit more risk, it's like putting something on a high shelf, ideally.

And that while you yourself don't want to be in a single person research study with the only body that you'll ever have in life,

What is good about it happening in the culture that you're documenting is that some of those people might find something useful and then they might put it through the normal testing and regulatory hurdles where everybody else can benefit from it.

Jasmine's son.

You can find her work at her sub stack.

We'll have a link to that sub stack and to her peptides piece in the show notes.

And you can usually find Ezra Marcus at New York Magazine.

We'll have a link to his peptides reporting in the show notes as well.

This week for the credits, something a little different.

One of our listeners, Ned Wilson, wrote in and asked if he could read them for us.

Ned works in film and television.

He's a longtime listener to this show.

He's also a finder, one of our listeners who financially supports our show at the highest possible level.

When someone who is paying for your work asks if they can do your work for you, what answer could you give but yes?

Take it away, Ned.